We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
FCDO travel advice for Peru. Includes safety and security, insurance, entry requirements and legal differences.
Information for British citizens moving to or living in Pakistan, including guidance on residency, healthcare and property.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
This Tax Information and Impact Note is about amendments to the scope of the zero-rate for drugs dispensed on the prescription of an appropriate practitioner.
Information for British citizens moving to or living in Chad, including guidance on residency, healthcare, security and education.
Deficiencies in Omega’s pharmacovigilance system are not thought to affect the safety of the products that they market.
Information for British citizens moving to or living in South Korea, including guidance on residency, healthcare, driving and more.
An annual report including information on prescription items dispensed and net ingredient cost.
UK companies who have their licence to manufacture or wholesale medicines terminated and cancelled.
The Competition Appeal Tribunal has unanimously upheld the CMA’s decision condemning a pharmaceutical supplier for excessive pricing of medicines sold to the NHS.
Information for British citizens moving to or living in Burkina Faso, including guidance on residency, healthcare and driving.
The report compares expenditure on medicines between primary care, secondary care and prescriptions written in secondary care but dispensed in the community.
The government's summary of an EU Commission proposal to amend EU legislation relating to medicinal products for human use and the impact on Northern Ireland.
First published during the 2022 to 2024 Sunak Conservative government
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).